108 References 1. Claeys L, Storoni S, Eekhoff M, et al. Collagen transport and related pathways in Osteogenesis Imperfecta. Hum Genet. 2021; 140: 1121–41. 2. Starr SR, Roberts TT, Fischer PR. Osteogenesis Imperfecta: Primary Care. Pediatr Rev 2010; 31: e54–64. 3. Van Dijk FSS, Sillence DOO. Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A 2014; 164: 1470–81. 4. Steiner R, Adsit J, Basel D. COL1A1/2-Related Osteogenesis Imperfecta. GeneReviews. 2013. DOI:NBK1295 [bookaccession]. 5. Gooijer K, Rondeel JMM, van Dijk FS, Harsevoort AGJ, Janus GJM, Franken AAM. Bleeding and bruising in Osteogenesis Imperfecta: International Society on Thrombosis and Haemostasis bleeding assessment tool and haemostasis laboratory assessment in 22 individuals. Br J Haematol 2019. DOI:10.1111/bjh.16097. 6. Malfait F, Paepe A De. Bleeding in the heritable connective tissue disorders: Mechanisms, diagnosis and treatment. Blood Rev 2009; 23. DOI:10.1016/j.blre.2009.06.001. 7. Artoni A, Bassotti A, Marinelli B, et al. Hemostatic abnormalities in patients with ehlers‐danlos syndrome. 2018; : 1–7. 8. Siegel BM, Friedman IA, Schwartz SO. Hemorrhagic disease in osteogenesis imperfecta Study of platelet functional defect. Am J Med 1957. 9. Hathaway WE, Solomons CC, Ott JE, Ott E. Platelet Function and Pyrophosphates in Osteogenesis Imperfecta. Blood 1972; 39. 10. Estes JW. Platelet size and function in the heritable disorders of connective tissue. Ann Intern Med 1968; 68: 1237–49. 11. Evensen SA, Myhre L, Stormorken H. Haemostatic studies in osteogenesis imperfecta. Scand J Haematol 1984; 33: 177–9. 12. Boender J, Kruip MJHA, Leebeek FWG. A diagnostic approach to mild bleeding disorders. Journal of Thrombosis and Haemostasis 2016; 14: 1507–16. 13. Pereira J, Quiroga T, Mezzano D. Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: A definitive diagnosis is often not possible. Semin Thromb Hemost. 2008; 34. DOI:10.1055/s-0028-1104544. 14. F. Rodeghiero AT and GC. How to estimate bleeding risk in mild bleeding disorders. Journal of Thrombosis and Haemostasis 2007; 5: 157–66. 15. Deforest M, Grabell J, Albert S, et al. Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease. Haemophilia 2015; 21: e384–8.
RkJQdWJsaXNoZXIy MTk4NDMw